[{"NetIncomeLoss_3_Q3_USD":-31603000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":7500000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4028000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":10099134.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":10109847.0,"InterestAndOtherIncome_3_Q3_USD":74000.0,"InterestAndOtherIncome_1_Q3_USD":7000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":3.65,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":22406000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-21000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.83,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3_Q3_shares":3408861.0,"CurrentFederalTaxExpenseBenefit_3_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":108413000.0,"OperatingLeaseExpense_3_Q3_USD":211000.0,"OperatingLeaseExpense_1_Q3_USD":70000.0,"TemporaryEquitySharesOutstanding_0_Q3_shares":48958829.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":175745000.0,"CurrentStateAndLocalTaxExpenseBenefit_3_Q3_USD":0.0,"CommonStockSharesIssued_0_Q3_shares":10109847.0,"Assets_0_Q3_USD":110106000.0,"DepreciationAndAmortization_1_Q3_USD":5000.0,"ShareBasedCompensation_3_Q3_USD":4636000.0,"DepreciationAndAmortization_3_Q3_USD":13000.0,"Liabilities_0_Q3_USD":10872000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":13601000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":3.65,"TemporaryEquityLiquidationPreference_0_Q3_USD":178106000.0,"TemporaryEquitySharesAuthorized_0_Q3_shares":57932090.0,"ConvertiblePreferredStockSharesIssuedUponConversion_0_Q3_shares":48958829.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q3_USD":200000.0,"NumberOfReportableSegments_3_Q3_Segment":1.0,"CommonStockValue_0_Q3_USD":10000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":300000.0,"TemporaryEquitySharesIssued_0_Q3_shares":48958829.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":105530000.0,"RestrictedCash_0_Q3_USD":107000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":1128000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":6340000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":85000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3689000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q3_USD":0.001,"OtherAssetsNoncurrent_0_Q3_USD":1644000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":105383000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":1.47,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":56475053.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2781000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":83722000.0,"CommonStockSharesOutstanding_0_Q3_shares":10109847.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":7001747.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q3_USD":340000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":126000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4238000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-21787000.0,"LiabilitiesCurrent_0_Q3_USD":10816000.0,"AccountsPayableCurrent_0_Q3_USD":4476000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":105490000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3030000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":27000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":96609000.0,"TemporaryEquityValueExcludingAdditionalPaidInCapital_0_Q3_USD":175745000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q3_USD":22406000.0,"AdditionalPaidInCapital_0_Q3_USD":9295000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":18747.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":106631000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":15371000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":49000.0,"NetIncomeLoss_1_Q3_USD":-17622000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-85816000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":2857918.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7001747.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":21000.0,"CommonStockSharesAuthorized_0_Q3_shares":80529575.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q3_USD":0.0,"OperatingIncomeLoss_3_Q3_USD":-31677000.0,"OperatingIncomeLoss_1_Q3_USD":-17629000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":6.38,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":1.43,"LiabilitiesAndStockholdersEquity_0_Q3_USD":110106000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":822000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":24177000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":4636000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":14923000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":175000.0,"OperatingExpenses_3_Q3_USD":31677000.0,"OperatingExpenses_1_Q3_USD":17629000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":4259000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.13,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.74,"ProfitLoss_3_Q3_USD":-31603000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":56000.0,"StockholdersEquity_0_Q3_USD":-76511000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4238000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q3_USD":625000.0,"Ticker":"AVIR","CIK":"1593899","name":"ATEA PHARMACEUTICALS, INC.","OfficialName":"Atea Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"530979271.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20201210"}]